Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study
OBJECTIVES This genetics-based study aimed to evaluate the relationships of long-term lipid-lowering agents on lung-related diseases (LRD) outcomes. METHODS We extracted genetic variations of six drug target genes from a major genome-wide association study of low-density lipoprotein cholesterol (LDL...
Saved in:
Main Authors: | Haifeng Yu, Xiaofei Zhang, Bian Wen, Shuo Hu, Bin Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | All Life |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/26895293.2024.2329440 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations between lipid-lowering drugs and urate and gout outcomes: a Mendelian randomization study
by: Min Liu, et al.
Published: (2025-01-01) -
Genetic Insights Into Lipid Traits and Lipid-Modifying Drug Targets in Pregnancy Complications: A Two-Sample Mendelian Randomization Study
by: Shao H, et al.
Published: (2025-01-01) -
The association of lipids and novel non-statin lipid-lowering drug target with osteoporosis: evidence from genetic correlations and Mendelian randomization
by: Qingcong Zheng, et al.
Published: (2025-02-01) -
Mendelian randomization study of serum uric acid levels and urate-lowering drugs on pulmonary arterial hypertension outcomes
by: Xiaoling Yao, et al.
Published: (2025-02-01) -
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
by: Liwan Fu, et al.
Published: (2025-02-01)